NKGen Biotech, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -326 | -300 | -300 | |
EBITDA | -15,115 | -3,987 | -32,861 | -32,666 |
EBIT | -15,441 | -4,313 | -33,161 | -32,966 |
Net Income | -16,088 | -5,382 | -33,606 | -33,177 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,999 | -4,034 | -6,957 | -13,977 |
Cash | 79 | 284 | 276 | 8,786 |
Basic Shares | 24,168 | 21,935 | 21,888 | 13,397 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $77 | $426 |
Gross Profit | -1,203 | 59 | 396 |
EBITDA | -28,543 | -23,231 | -20,701 |
EBIT | -29,746 | -24,441 | -21,945 |
Net Income | -82,954 | -26,754 | -23,265 |
Net Change In Cash | 0 | 77 | 426 |
Free Cash Flow | -21,996 | -22,720 | -20,007 |
Cash | 26 | 117 | 351 |
Basic Shares | 15,426 | 6,356 | 21,451 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.66 |
2024-03-31 | -$0.24 |
2023-12-31 | -$1.53 |
2023-09-30 | -$2.47 |
